Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-663-0 | CAS number: -
Endpoint summary
Administrative data
Description of key information
The repeated dose toxicity of Diacid 1550, the free acid of the target substance, was investigated in a combined 28-d repeated dose toxicity/reproscreening study that was performed in accordance with OECD 422 and under GLP conditions. Diacid 1550 was administered orally via the diet at 0, 500, 3000, and 15000 ppm. Based on increased liver weights and increased centrilobular hepatocyte hypertrophy in males and females at the highest dose, the parental NOAEL was considered to be 3000 ppm, corresponding to 271 mg/kg bw/day of free acid, under the conditions of this study. Considering the change in molecular weight of the potassium salt, this value becomes corrected to 298 mg/kg bw/d to be used for hazard and risk assessment of the target substance, the corresponding potassium salt.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEL
- 298 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- System:
- hepatobiliary
- Organ:
- liver
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Based on the results of a subacute oral toxicity study resulting in effects only far above the threshold for classification, the substance is not subject for STOT RE (specific target organ toxicity, repeat exposure) according to CLP (Regulation EC No 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
